| S7858 |
Dibutyryl cAMP (db cAMP/Bucladesine) sodium
|
Bucladesine sodium is a cell-permeable PKA activator by mimicing the action of endogenous cAMP. Dibutyryl-cAMP (Bucladesine) is also a phosphodiesterase (PDE) inhibitor.
|
-
Cell, 2025, S0092-8674(25)00735-4
-
Nat Neurosci, 2025, 28(6):1174-1184
-
Nat Commun, 2025, 16(1):6151
|
|
| S7857 |
8-Bromo-cAMP (8-Br-cAMP) Sodium Salt
|
8-Bromo-cAMP sodium salt is a cell permeable analog of cAMP that activates cyclic-AMP-dependent protein kinase with a Ka value of 0.05 μM; and a PKA activator.
|
-
Nat Cell Biol, 2025, NONE
-
Stem Cell Res Ther, 2025, 16(1):336
-
Elife, 2024, 13RP97507
|
|
| E4793 |
Bucladesine calcium
|
Bucladesine calcium (Dibutyryl-cAMP Calcium Salt, DBcAMP calcium salt) is a cell-permeable analog of cyclic AMP. It serves as a potent activator of protein kinase A (PKA) and mimics the effects of endogenous cAMP. It also inhibits phosphodiesterase (PDE) activity, with the potential to treat congestive heart failure, wound healing, and inflammation.
|
-
Regen Ther, 2025, 29:499-505
|
|